share_log

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight

Benzinga ·  Dec 18 21:57

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) from Overweight to Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment